Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis

Arthritis and Rheumatism

Volumn 62, Issue 2, 2010, Pages 472-477

  Asquith, Darren L ^a   Miller, Ashley M ^a   Hueber, Axel J ^a   Liew, Foo Y ^a   Sattar, Naveed ^a   McInnes, Iain B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; AUTOANTIBODY; COLLAGEN; COLLAGEN TYPE 2; CYTOKINE; FREUND ADJUVANT; IMMUNOGLOBULIN G2A ANTIBODY; LIPID; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; LIPID BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAM FEEDING; WILD TYPE;

ANIMALS; ANTIBODIES; APOLIPOPROTEINS E; ARTHRITIS, EXPERIMENTAL; ATHEROSCLEROSIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RISK FACTORS;

EID: 75749091474     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27205     Document Type: Article

References (14)

1. Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
2. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009;38:366-71.
3. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
4. Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis 2009;68:460-9.
5. Daugherty A. Mouse models of atherosclerosis. Am J Med Sci 2002;323:3-10.
6. Inglis JJ, Criado G, Medghalchi M, Andrews M, Sandison A, Feldmann M, et al. Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res Ther 2007;9:R113.
7. Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1: 507-37.
8. Feng X, Li H, Rumbin AA, Wang X, La Cava A, Brechtelsbauer K, et al. ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J Lipid Res 2007;48:794-805.
9. Ma Z, Choudhury A, Kang SA, Monestier M, Cohen PL, Eisenberg RA. Accelerated atherosclerosis in ApoE deficient lupus mouse models. Clin Immunol 2008;127:168-75.
10. Terkeltaub RA, Dyer CA, Martin J, Curtiss LK. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils: characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991;87:20-6.
11. Hasegawa H, Nishi S, Ito S, Saeki T, Kuroda T, Kimura H, et al. High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. Arthritis Rheum 1996; 39:1728-32.
12. Lee SI, Lee SY, Yoo WH. Association of apolipoprotein E polymorphism with bone mineral density in postmenopausal women with rheumatoid arthritis. Rheumatology (Oxford) 2005; 44:1067-8.
13. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003;171:6173-7.
14. Hamer ER, Apfel MI, Carvalho JJ, Pereira MJ, Levy RA. Evaluation of the cholesterol influence in type II collagen-induced arthritis in DBA/1J mice: an autoradiographic study. J Cell Mol Med 2002;6:407-14.